Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors

The 3-chymotrypsin-like cysteine protease (3CLpro) of severe acute respiratory syndrome conoravirus 2 (SARS-CoV-2) remains a promising therapeutic target to combat COVID-19. Our group recently described a novel duplexed biochemical assay that combines self-assembled monolayers of alkanethiolates on...

Descripción completa

Detalles Bibliográficos
Autores principales: Scholle, Michael D., O'Kane, Patrick T., Dib, Sandra, Gurard-Levin, Zachary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906060/
https://www.ncbi.nlm.nih.gov/pubmed/35278580
http://dx.doi.org/10.1016/j.antiviral.2022.105279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906060/
https://www.ncbi.nlm.nih.gov/pubmed/35278580
http://dx.doi.org/10.1016/j.antiviral.2022.105279

Ejemplares similares